GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » COGS-to-Revenue

JD Health International (HKSE:06618) COGS-to-Revenue : 0.79 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is JD Health International COGS-to-Revenue?

JD Health International's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$22,704 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$28,897 Mil.

JD Health International's COGS to Revenue for the six months ended in Dec. 2023 was 0.79.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. JD Health International's Gross Margin % for the six months ended in Dec. 2023 was 21.43%.

JD Health International COGS-to-Revenue Historical Data

The historical data trend for JD Health International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International COGS-to-Revenue Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.74 0.75 0.77 0.79 0.78

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.78 0.79 0.77 0.79

JD Health International COGS-to-Revenue Calculation

JD Health International's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=45571.865 / 58549.919
=0.78

JD Health International's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=22703.862 / 28897.206
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International  (HKSE:06618) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

JD Health International's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 22703.862 / 28897.206
=21.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

JD Health International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of JD Health International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (HKSE:06618) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:06078 HKSE:02273 HKSE:01951 HKSE:01515 HKSE:00708 HKSE:03309 HKSE:06639 HKSE:02373 HKSE:02138 HKSE:02219 HCA SAU:4013 SZSE:300015 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE
Traded in Other Exchanges
JDHIY:USA JDHIF:USA 8ZN:Germany
Address
No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
Website
https://ir.jdhealth.com
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
Executives
Liu Qiangdong Richard 2101 Beneficial owner
Jd Jiankang Limited 2101 Beneficial owner
Jd.com, Inc. 2201 Interest of corporation controlled by you

JD Health International (HKSE:06618) Headlines

No Headlines